Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial

dc.contributor.author	Antolín Novoa, Silvia
dc.date.accessioned	2017-06-07T06:53:13Z
dc.date.available	2017-06-07T06:53:13Z
dc.date.issued	2015
dc.identifier.issn	0008-5472
dc.identifier.uri	http://hdl.handle.net/20.500.11940/222
dc.language.iso	eng
dc.title	Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial
dc.type	Publicación de congreso
dc.authorsophos	Balmna, Judit
dc.authorsophos	Cruz, Cristina
dc.authorsophos	Garber, Judy
dc.authorsophos	Fidalgo, Jose A. Perez
dc.authorsophos	Lluch, Ana
dc.authorsophos	Tung, Nadine
dc.authorsophos	Antolin, Silvia
dc.authorsophos	Fernandez, Cristian
dc.authorsophos	Kahatt, Carmen
dc.authorsophos	Szyldergemajn, Sergio
dc.authorsophos	Matos, Arturo Soto
dc.authorsophos	Extremera, Sonia
dc.authorsophos	Baselga, Jose
dc.authorsophos	Isakoff, Steven J.
dc.identifier.sophos	17800
dc.issue.number	9
dc.journal.title	CANCER RESEARCH
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	75

Files in this item

Files	Size	Format	View
There are no files associated with this item.